Cyclosporine Adversely Affects Baroreflexes via Inhibition of ...

0022-3565/02/3011-346 –354$7.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics JPET 301:346–354, 2002

Vol. 301, No. 1 4487/972762 Printed in U.S.A.

Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control MAHMOUD M. EL-MAS, ELHAM A. AFIFY, AMAL G. OMAR, and FOUAD M. SHARABI Department of Pharmacology, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt Received August 28, 2001; accepted December 18, 2001

This article is available online at http://jpet.aspetjournals.org

ABSTRACT Previous studies have shown that the immunosuppressant drug cyclosporine A attenuates arterial baroreceptor function. This study investigated whether the modulatory effect of cyclosporine on baroreceptor function involves inhibition of the baroreflex-facilitatory effect of testosterone. The role of cardiac autonomic control in cyclosporine-testosterone baroreflex interaction was also investigated. Baroreflex curves relating bradycardic responses to increments in blood pressure evoked by phenylephrine were constructed in conscious, sham-operated, castrated rats and in testosterone-replaced castrated (CAS ⫹ T) rats in the absence and presence of cyclosporine. The slopes of the curves were taken as an index of the baroreflex sensitivity (BRS). Short-term (11–13 days) cyclosporine treatment or castration reduced plasma testosterone levels and caused similar attenuation of the reflex bradycardia, as indicated by the sig-

Cyclosporine A is a potent immunosuppressant agent used in organ transplantation to prolong the survival of allogenic grafts and in the treatment of autoimmune diseases (Cohen et al., 1984). However, the clinical use of cyclosporine is often associated with serious cardiovascular disorders such as hypertension (Schachter, 1988; Scherrer et al., 1990). Several mechanisms have been proposed to explain the hypertensive effect of cyclosporine such as sympathetic activation (Scherrer et al., 1990; Chiu et al., 1992), direct vasoconstriction (Xue et al., 1987), and/or endothelin release (Kon et al., 1990). Attenuation of arterial baroreceptor responsiveness is another mechanism that may contribute to cyclosporine-induced hypertension. Gerhardt et al. (1999) have shown that cyclosporine elevates blood pressure in kidney transplant recipients, and this effect was associated with a reduced baroreflex function. Cyclosporine has also been shown to shift the midranges of baroreflex control of sympathetic nerve activity and heart rate to higher arterial pressures (Ryuzaki et al., 1997). Spectral analysis of the arterial pressure-heart period relationship in patients with heart transplantation showed that cyclosporine reduces the overall gain Supported by the Faculty of Pharmacy, University of Alexandria, Egypt.

nificantly smaller BRS compared with sham-operated values (⫺0.97 ⫾ 0.07, ⫺0.86 ⫾ 0.06, and ⫺1.47 ⫾ 0.10 beats/min/mm Hg, respectively). The notion that androgens facilitate baroreflexes is further confirmed by the observation that testosterone replacement of castrated rats restored plasma testosterone and BRS to sham-operated levels. Cyclosporine had no effect on BRS in castrated rats but caused a significant reduction in CAS ⫹ T rats. Muscarinic blockade by atropine caused approximately 60% reduction in the BRS in sham-operated rats, an effect that was significantly and similarly diminished by castration, cyclosporine, or their combination. ␤-Adrenergic blockade by propranolol caused no significant changes in BRS. These findings suggest that cyclosporine attenuates baroreflex responsiveness via, at least partly, inhibition of the testosteroneinduced facilitation of cardiomotor vagal control.

of baroreflex responsiveness to orthostatic stimulus (Lucini et al., 2000). Notably, the attenuation of baroreflex responsiveness is considered as an important independent risk factor for cardiac mortality (Schwartz et al., 1984; Tsuji et al., 1994). The exact mechanism by which cyclosporine attenuates the baroreflex function, and whether it involves central or peripheral pathways, is not clear. It has been suggested that an imbalance between the sympathetic and parasympathetic activities due to an enhanced sympathetic tone may explain cyclosporine-induced baroreflex dysfunction (Gerhardt et al., 1999). Cyclosporine increases the production of thromboxane A2 and disturbs the prostaglandin (prostaglandin I2 and thromboxane A2) balance (Perico et al., 1986). Given that prostaglandin I2 increases the baroreceptor sensitivity (Chen et al., 1990), the altered prostaglandin profile may result in reduced baroreceptor sensitivity. Reported findings have shown that cyclosporine causes testicular dysfunction. Cyclosporine produces dose-dependent reductions in serum testosterone levels and intratesticular testosterone contents (Krueger et al., 1991; Bowman et al., 1997), and impairs spermatogenesis (Srinivas et al., 1998). The alterations in testicular function by cyclosporine

ABBREVIATIONS: HR, heart rate; BRS, baroreflex sensitivity; MAP, mean arterial pressure; CAS, castrated; CAS ⫹ T, testosterone-replaced CAS; CyA, cyclosporine A-treated; ANOVA, analysis of variance. 346

Cyclosporine-Testosterone Baroreflex Interaction

can be reversed by testosterone replacement therapy (Seethalakshmi et al., 1990). Interestingly, testosterone has been shown in a recent study from our laboratory to selectively modulate the baroreceptor control of reflex bradycardia versus no effect on reflex tachycardia (El-Mas et al., 2001). In the latter study, we provided the first experimental evidence that testosterone facilitates baroreflex function through a mechanism that involves enhancement of cardiac vagal activity. With this idea in mind, the ability of cyclosporine to reduce baroreflex responsiveness and serum testosterone levels raises the possibility that these two effects of cyclosporine are correlated. This assumption has not yet been investigated. The present study, therefore, addressed two important questions pertinent to the hypothesis that testosterone modulates cyclosporine-induced baroreflex impairment: first, whether cyclosporine reduces baroreceptor responsiveness via inhibition of the facilitatory effect of testosterone on baroreflexes; and second, whether alterations in the cardiac autonomic control contribute to cyclosporine-testosterone baroreflex interaction. To accomplish these goals, baroreflex curves relating reflex HR responses to increments in blood pressure evoked by phenylephrine were established in conscious, freely moving, sham-operated, castrated rats and in CAS ⫹ T rats treated with cyclosporine or vehicle. Baroreflex responsiveness was measured in the absence and presence of atropine (muscarinic blocker) or propranolol (␤-adrenergic blocker) to evaluate the roles of cardiac vagal and sympathetic activity, respectively, in the HR responses. The slopes of the curves were taken as an index of BRS. Plasma testosterone levels were also measured and correlated to changes in BRS.

Materials and Methods Male Wistar rats (230 –280 g; High Institute of Public Health, Alexandria, Egypt) were used in the present study. Castration. Castration was performed as described in our previous studies (El-Mas et al., 2001) and by others (Mills et al., 1992). A single 2- to 3-cm incision was made in the scrotum. The testes were isolated, tied off with sterile suture, and removed. The skin was sutured, and the rats were allowed 10 days prior to intravascular cannulation. Sham operation involved exposure of the testes without isolation. Each rat received an intramuscular injection of 60,000 U of penicillin G benzathine and penicillin G procaine (Penicid) and was housed in a separate cage. Intravascular cannulation was performed 10 days later. Intravascular Cannulation. The method described in our previous studies (El-Mas and Abdel-Rahman, 1992; El-Mas et al., 1997a,b) for measurement of blood pressure was adopted. Briefly, the rats were anesthetized by thiopental (50 mg/kg i.p.). Catheters (polyethylene 50) were placed in the abdominal aorta and vena cava via the femoral artery and vein for measurement of blood pressure and i.v. administration of drugs, respectively. The catheters were inserted about 5 cm into the femoral vessels and secured in place with sutures. The arterial catheter was connected to a GouldStatham (Oxnard, CA) pressure transducer, and blood pressure was displayed on a Grass polygraph (model 7D; Grass Instruments, Quincy, MA). The heart rate was computed from blood pressure waveforms by a Grass tachograph and displayed on another channel of the polygraph. Finally, the catheters were tunneled subcutaneously and exteriorized at the back of the neck between the scapulae. The catheters were flushed with heparin (100 U/ml) and plugged by stainless steel pins. Incisions were closed by surgical clips and swabbed with pov-

347

idone-iodine solution. Each rat received an intramuscular injection of 60,000 U of penicillin G benzathine and penicillin G procaine in an aqueous suspension (Penicid) and was housed in a separate cage. The experiment started 24 and 72 h later. Experiments were performed in strict accordance with institutional animal care and use guidelines. Measurement of Plasma Testosterone. A blood sample (0.4 ml) was withdrawn from the arterial line of each rat on the morning of the primary experiment day immediately before baroreflex testing. The plasma testosterone level was measured by radioimmunoassay (Diagnostic Products Corp., Los Angeles, CA). Protocols and Experimental Groups. A total of six groups of male rats (sham, castrated, CAS ⫹ T, CyA, CAS ⫹ CyA, and CAS ⫹ CyA ⫹ T) were used in this study to investigate the modulatory effect of testosterone on cyclosporine-induced attenuation of reflex HR responses and the relative contributions of vagal and sympathetic activities to these responses. Each rat in a particular group was employed in two experiments (24 and 72 h after instrumentation) to test the effect of atropine or propranolol on reflex HR responses to peripherally mediated increases in MAP evoked by phenylephrine. In the primary experiment, approximately 50% of the rats in a given group received atropine and the other 50% received propranolol. In the secondary experiment, the administration of atropine and propranolol was crossed over. Cyclosporine (20 mg/kg, dissolved in sesame oil) or an equal volume of vehicle was injected subcutaneously in single daily doses for 13 consecutive days. The first dose of cyclosporine or vehicle was given 11 days before the primary experiment of baroreflex testing. Testosterone (1 mg dissolved in sesame oil) was injected subcutaneously in single daily doses for 8 consecutive days starting 5 days before the primary experiment (Seidenfeld et al., 1980; El-Mas et al., 2001). The last dose of cyclosporine, testosterone, or vehicle was injected on the morning of the secondary experiment day. On the day of the experiment (24 or 72 h after intravascular cannulation), the arterial catheter was connected to a pressure transducer for measurement of blood pressure and HR as mentioned above. A period of 30 min was allowed at the beginning of the experiment for stabilization of blood pressure and HR. Baroreflex curves of phenylephrine were generated as previously described (Abdel-Rahman, 1999; El-Mas et al., 2001) in all rats before and 10 min after atropine or propranolol (1 mg/kg each, i.v.). Comparison of the BRS before and after atropine or propranolol would allow a proper assessment of the relative contributions of the vagal and sympathetic autonomic components to the reflex HR responses (Abdel-Rahman, 1999; El-Mas et al., 2001). The doses of atropine and propranolol used in the present study have been shown to be adequate for muscarinic and ␤-adrenergic blockade, respectively (Coleman, 1980; Abdel-Rahman, 1999; El-Mas et al., 2001). For the generation of the baroreflex curves, randomized i.v. doses of phenylephrine (0.5– 8 ␮g/kg) were injected at 5-min intervals as in our previous studies (El-Mas and Abdel-Rahman, 1997; El-Mas, 1998, 1999). This time interval was adequate for blood pressure and HR to regain baseline levels. Phenylephrine was dissolved in saline, and the injection volume was kept constant at 0.05 ml/100 g of body weight with a flush volume of approximately 0.1 ml of saline. The MAP (diastolic plus one-third pulse pressure) and HR values before and after phenylephrine administration were measured, and the peak changes in both variables (⌬MAP and ⌬HR) were used for construction of the baroreflex curves. Drugs. Testosterone (Organon NV, Oss, The Netherlands), phenylephrine hydrochloride, atropine sulfate, propranolol hydrochloride (Sigma-Aldrich, St. Louis, MO), thiopental (Biochemie GmbH, Vienna, Austria), povidone-iodine solution (Betadine; Nile Pharmaceutical Co., Cairo, Egypt), and Penicid (Cid Pharmaceutical Co., Cairo, Egypt) were purchased from commercial vendors. Cyclosporine A was a gift from Novartis Pharma, AG (Basel, Switzerland). A fresh solution of cyclosporine in sesame oil was prepared every 3 days and kept in the refrigerator.

348

El-Mas et al.

Statistical Analysis. Values are expressed as mean ⫾ S.E.M. The relationship between increases in MAP and associated decreases in HR was assessed by regression analysis for individual animals as described in our previous studies (El-Mas and Abdel-Rahman, 1992, 1998; El-Mas et al., 2001). The regression coefficient (slope of the regression line) expressed as beats per minute per mm Hg was taken as an index of BRS. Analysis of variance (ANOVA) followed by a Newman-Keuls post hoc analysis was used for multiple comparisons with the level of significance set at P ⬍ 0.05.

Results Cyclosporine-Testosterone Baroreflex Interaction. The baseline values of MAP measured in conscious, freely moving rats on the day of the experiment were similar in all groups of rats (Table 1). The baseline HR values were not altered by castration or testosterone replacement, whereas they were significantly (P ⬍ 0.05) increased in cyclosporine-treated groups (CyA, CAS ⫹ CyA, and CAS ⫹ CyA ⫹ T) compared with sham-operated values (Table 1). Pooled data obtained prior to atropine or propranolol administration showed that i.v. administration of phenylephrine (0.5– 8 ␮g/kg) produced dose-related increases in MAP that were associated with reflex decreases in HR (Table 2). Multiple comparisons (ANOVA) of the mean pressor responses to phenylephrine revealed that these responses were not affected by short-term castration but showed significant (P ⬍ 0.05; ANOVA) reductions by cyclosporine treatment (20 mg/kg/day for 11–13 days) compared with sham-operated values (Table 2). The reflex bradycardic responses were significantly (P ⬍ 0.05) reduced by castration and by cyclosporine treatment (Table 2). Analysis of the baroreflex curves, relating decreases in HR responses to phenylephrine-induced increases in MAP, revealed a lesser steep regression line in the case of castrated or cyclosporine-treated rats; i.e., for a comparable rise in MAP there was a significantly (P ⬍ 0.05) smaller bradycardic response in these two groups compared with shamoperated rats (Fig. 1). The slope of the linear regression line, which represented BRS, was significantly (P ⬍ 0.05) and similarly reduced in castrated or cyclosporine-treated compared with sham-operated rats (⫺0.86 ⫾ 0.06, ⫺0.92 ⫾ 0.06, and ⫺1.47 ⫾ 0.10 beats/min/mm Hg, respectively; Fig. 2A). On the other hand, treatment of castrated rats with cyclosporine caused no changes in the baroreflex curve (Fig. 1) or in BRS (Fig. 2A). The subcutaneous injection of testosterone (1 mg/day for 6 – 8 days) to castrated rats increased the reflex bradycardic responses to phenylephrine (Table 2) and shifted the baroreflex curve toward that of the sham-operated rats (Fig. 1). The TABLE 1 Baseline values of MAP (mm Hg) and HR (beats/min) in conscious, freely moving rats Values are mean ⫾ S.E.M. of pooled baseline data obtained from atropine and propranolol experiments. Group

n

MAP

HR

Sham CAS CAS ⫹ T CyA CAS ⫹ CyA CAS ⫹ CyA ⫹ T

13 13 13 16 12 13

108.6 ⫾ 3.9 110.6 ⫾ 2.2 105.3 ⫾ 2.8 111.3 ⫾ 3.9 103.1 ⫾ 2.8 99.2 ⫾ 3.1

376.0 ⫾ 11.7 400.3 ⫾ 8.4 402.5 ⫾ 11.6 472.7 ⫾ 10.7* 475.0 ⫾ 10.9* 452.5 ⫾ 11.6*

* P ⬍ 0.05 compared with sham-operated value.

BRS (⫺1.45 ⫾ 0.10 beats/min/mm Hg) of CAS ⫹ T rats was significantly (P ⬍ 0.05) higher than that of castrated rats and similar to that of sham-operated rats (Fig. 2A). In CAS ⫹ T rats, treatment with cyclosporine caused an upward shift in the baroreflex curve and significantly (P ⬍ 0.05) reduced BRS (Figs. 1 and 2A). The correlation coefficients of the regression lines were highly significant (P ⬍ 0.001) and ranged from 0.89 to 0.99. To eliminate any role for the reduced pressor responsiveness to phenylephrine observed in cyclosporine-treated rats and its possible contribution to cyclosporine-induced impairment of reflex bradycardia, the HR responses to similar increases (approximately 35 mm Hg) in MAP were computed for individual rats, regardless of the dose of phenylephrine used, and the BRS was measured by calculation of the ratio ⌬HR/⌬MAP (El-Mas and Abdel-Rahman, 1993). The results showed that the reflex bradycardic (Fig. 3B) and BRS (Fig. 3C) responses, evoked by comparable increases in MAP (Fig. 3A), were significantly (P ⬍ 0.05) reduced by cyclosporine compared with the sham-operated rats. Similar reductions in the reflex bradycardia (Fig. 3B) and BRS (Fig. 3C) were demonstrated in CAS and CAS ⫹ CyA rats. Changes in plasma testosterone levels evoked by castration, testosterone replacement, cyclosporine, or their combinations are shown in Fig. 2B. Plasma testosterone levels were significantly (P ⬍ 0.05) reduced by castration or cyclosporine compared with sham-operated levels (15.6 ⫾ 5.3, 41.6 ⫾ 9.9, and 105.4 ⫾ 21.2 ng/dl, respectively). Treatment of CAS or CAS ⫹ CyA rats with testosterone restored the physiological levels of the hormone (Fig. 2B). Effects of Muscarinic or ␤-Adrenergic Blockade on Reflex Heart Rate Responses. The effects of muscarinic or ␤-adrenergic blockade with atropine and propranolol, respectively, on peripherally mediated increases in MAP and reciprocal changes in HR are shown in Table 3 and Figs. 4 and 5. In sham-operated rats, muscarinic blockade by atropine (1 mg/kg, i.v.) caused an upward shift of the baroreflex curve relating the pressor responses of phenylephrine to the associated reflex bradycardic responses and elicited a significant reduction in the BRS from ⫺1.36 ⫾ 0.14 to ⫺0.59 ⫾ 0.11 beats/min/mm Hg (Fig. 4A). Qualitatively similar effects for atropine were demonstrated in castrated and in cyclosporinetreated rats (Fig. 4, B and D). However, the percentage of reductions in BRS by atropine in castrated and cyclosporinetreated rats (30.34 ⫾ 9.98 and 40.15 ⫾ 7.99%, respectively) were significantly less than that of sham-operated rats (57.67 ⫾ 4.37%; Table 3). The atropine-induced reductions in BRS of CAS ⫹ CyA rats were not statistically different from those of castrated or cyclosporine-treated rats (Table 3). The effects of atropine on the baroreflex curves and BRS were restored to sham-operated levels after testosterone replacement in CAS but not in CAS ⫹ CyA rats (Fig. 4, C and F; Table 3). Contrary to the effect of atropine, ␤-adrenergic blockade by propranolol (1 mg/kg, i.v.) in sham-operated rats caused a slight upward shift in the baroreflex curve and insignificant decreases in the BRS from ⫺1.59 ⫾ 0.14 to ⫺1.24 ⫾ 0.21 beats/min/mm Hg (Fig. 5A). This represented a 22.35 ⫾ 10.55% reduction in the BRS (Table 3), which suggests a minor contribution of the cardiac sympathetic activity in the reflex bradycardia. The effects of propranolol on the baroreflex curve of phenylephrine (Fig. 5) and the percentage re-


349

TABLE 2 Increases in MAP (mm Hg) evoked by phenylephrine and associated reflex decreases in HR (beats per minute) in conscious, freely moving rats Values are mean ⫾ S.E.M. of pooled data obtained before atropine or propranolol administration. Phenylephrine Group 0.5

1.0

2.0

4.0

8.0

␮g/kg, i.v.

Sham ⌬MAP ⌬HR CAS ⌬MAP ⌬HR CAS ⫹ T ⌬MAP ⌬HR CyA ⌬MAP ⌬HR CAS ⫹ CyA ⌬MAP ⌬HR CAS ⫹ CyA ⫹ T ⌬MAP ⌬HR

7.7 ⫾ 1.0 ⫺10.6 ⫾ 3.4

17.8 ⫾ 2.3 ⫺24.2 ⫾ 3.3

27.8 ⫾ 2.3 ⫺35.4 ⫾ 3.4

41.1 ⫾ 2.4 ⫺53.5 ⫾ 3.8

52.1 ⫾ 1.6 ⫺81.9 ⫾ 5.5

7.2 ⫾ 1.8 ⫺5.0 ⫾ 1.5

15.0 ⫾ 2.1 ⫺13.9 ⫾ 2.3*

23.1 ⫾ 2.9 ⫺21.5 ⫾ 2.4*

35.7 ⫾ 3.8 ⫺31.1 ⫾ 3.0*

49.7 ⫾ 4.5 ⫺42.3 ⫾ 3.7*

7.0 ⫾ 1.3 ⫺9.0 ⫾ 1.6

12.3 ⫾ 1.7 ⫺20.0 ⫾ 2.8

24.0 ⫾ 3.0 ⫺28.0 ⫾ 2.7

33.3 ⫾ 3.8 ⫺45.0 ⫾ 4.2

46.0 ⫾ 4.2 ⫺71.2 ⫾ 7.8

4.9 ⫾ 1.0 ⫺2.5 ⫾ 1.4

9.5 ⫾ 1.4* ⫺6.5 ⫾ 1.7*

14.5 ⫾ 1.7* ⫺14.1 ⫾ 2.8*

24.0 ⫾ 2.0* ⫺22.5 ⫾ 3.0*

39.1 ⫾ 2.4* ⫺38.4 ⫾ 3.2*

9.4 ⫾ 4.6 ⫺2.8 ⫾ 1.2

9.4 ⫾ 1.4* ⫺7.5 ⫾ 2.0*

13.1 ⫾ 1.6* ⫺9.2 ⫾ 1.8*

19.1 ⫾ 2.5* ⫺16.7 ⫾ 2.7*

32.6 ⫾ 3.9* ⫺26.3 ⫾ 3.4*

5.4 ⫾ 1.1 ⫺6.9 ⫾ 2.2

8.4 ⫾ 1.7* ⫺10.8 ⫾ 2.8*

12.9 ⫾ 1.8* ⫺15.0 ⫾ 2.9*

22.1 ⫾ 2.5* ⫺20.9 ⫾ 3.7*

35.3 ⫾ 3.1* ⫺27.7 ⫾ 3.3*

* P ⬍ 0.05 compared with sham-operated values.

Fig. 1. Baroreflex curves relating decrements in heart rate to increments in mean arterial pressure evoked by phenylephrine in conscious, freely moving, sham-operated, CAS rats and in CAS ⫹ T rats in the presence and absence of CyA. Values are the means of the pooled data obtained prior to atropine or propranolol administration. The standard errors of the means were omitted to reduce overcrowding of the figure.

duction in BRS (Table 3) were not significantly altered by castration, cyclosporine, or their combination.

Discussion Cyclosporine A, one of the most effective immunosuppressant agents, has been shown in clinical and experimental studies to impair the arterial baroreceptor function (Ryuzaki et al., 1997; Gerhardt et al., 1999; Lucini et al., 2000). The cyclosporine-induced baroreflex dysfunction

Fig. 2. Effects of CyA on BRS (panel A) and plasma testosterone levels (panel B) in conscious, freely moving, sham-operated, CAS rats and in CAS ⫹ T rats. Values are expressed as mean ⫾ S.E.M. of the pooled data obtained prior to atropine or propranolol administration. 多 and #, P ⬍ 0.05 compared with sham-operated and CAS ⫹ T rat values, respectively.

350

El-Mas et al. TABLE 3 Percentage reductions in the baroreflex sensitivity measured by phenylephrine in conscious rats evoked by muscarinic or ␤-adrenergic blockade with atropine and propranolol, respectively Values are mean ⫾ S.E.M. Atropine

Propranolol

Group

Sham CAS CAS ⫹ T CyA CAS ⫹ CyA CAS ⫹ CyA ⫹ T

n

% Reduction

n

% Reduction

7 7 6 8 5 6

57.67 ⫾ 4.37 30.34 ⫾ 9.98* 54.34 ⫾ 9.44 40.15 ⫾ 7.99* 21.30 ⫾ 7.33* 25.61 ⫾ 13.32*

6 6 7 8 7 7

22.35 ⫾ 10.55 2.18 ⫾ 10.01 17.44 ⫾ 12.60 10.54 ⫾ 10.19 17.05 ⫾ 15.64 12.03 ⫾ 10.11

* P ⬍ 0.05 compared with sham-operated values.

Fig. 3. Effects of CyA on heart rate responses (panel B) and BRS (panel C) values evoked by similar increases in mean arterial pressure (panel A) in conscious, freely moving, sham-operated, CAS rats and in CAS ⫹ T rats. Values are expressed as mean ⫾ S.E.M. of the pooled data obtained prior to atropine or propranolol administration. 多 and #, P ⬍ 0.05 compared with sham-operated and CAS ⫹ T rat values, respectively.

has been implicated in the pressor effect that develops during cyclosporine therapy (Gerhardt et al., 1999; Lucini et al., 2000). A similar correlation between hypertension and baroreflex impairment has been reported in humans (Goldstein, 1983) and experimental models of hypertension (Gordon and Mark, 1983; Abdel-Rahman and Wooles,

1987). The exact mechanism that underlies baroreflex impairment by cyclosporine is not clear. One possible explanation may involve the ability of cyclosporine to produce testicular dysfunction and lower plasma testosterone levels (Krueger et al., 1991; Bowman et al., 1997). Testosterone has been shown in a recent study from our laboratory to facilitate baroreflex responsiveness via enhancing cardiac vagal activity (El-Mas et al., 2001). The present study tested the hypothesis that cyclosporine impairs baroreflex function via reducing plasma levels of testosterone and inhibiting its facilitatory effect on cardiac vagal control. The effects of short-term cyclosporine administration on plasma testosterone levels and reflex bradycardic responses that developed secondary to baroreceptor loading by phenylephrine were evaluated in sham-operated rats as well as in castrated rats with and without testosterone replacement. Baroreflex curves relating increases in MAP evoked by phenylephrine to the associated decreases in HR were constructed, and the slopes were taken as a measure of BRS (El-Mas and Abdel-Rahman, 1992, 1998; El-Mas et al., 2001). The relative contributions of the sympathetic and parasympathetic components to the reflex bradycardic responses were also investigated. The present findings that castration impairs arterial baroreceptor control of reflex bradycardia and that testosterone replacement restores BRS to sham-operated levels support our previous findings (El-Mas et al., 2001) and suggest that testosterone exerts a favorable effect on baroreceptor function. The current study presents evidence that implicates the male gonadal hormone testosterone in the depressant effect of cyclosporine on baroreflexes. This notion is supported by two observations. First, short-term castration or cyclosporine treatment caused remarkable reductions in plasma testosterone levels and similar attenuation of the baroreceptor control of reflex bradycardia, as suggested by the significant reduction in the slope of the regression line (BRS), relating peripherally mediated elevations in mean arterial pressure to the associated decreases in heart rate. Second, the ability of cyclosporine to impair reflex bradycardia was abolished when administered to testosterone-depleted (i.e., castrated) rats. Comparison of the slopes of the regression lines revealed that BRS values in castrated, cyclosporine-treated, and CAS ⫹ CyA rats were not statistically different. Taken together, the findings that cyclosporine lowered plasma testosterone levels and attenuated reflex bradycardia in sham-operated but not in castrated rats establish the first experimental evidence that inhibition of testosterone-mediated baroreflex facilitation may account, at


351

Fig. 4. Effect of muscarinic blockade by atropine (1 mg/kg, i.v.) on baroreflex curves relating decreases in heart rate to phenylephrine-induced elevations in mean arterial pressure in conscious, freely moving, sham-operated, CAS and CAS ⫹ T rats in the presence and absence of CyA. Insets show the slopes (BRS, beats per minute per mm Hg) of the baroreflex curves. Values are expressed as mean ⫾ S.E.M. 多, P ⬍ 0.05 compared with the “before” values.

least partly, for the deleterious effect of cyclosporine on baroreflex function. We have recently shown that the facilitatory effect of testosterone on baroreceptor control of reflex bradycardia is mediated via enhancement of cardiac vagal activity (ElMas et al., 2001). The present study, therefore, attempted to investigate whether cyclosporine impairs baroreflexes through interfering with the modulatory effect of testosterone on vagal function. This objective was accomplished by evaluating the effect of selective muscarinic or ␤-adrenergic blockade by atropine and propranolol, respectively, on reflex bradycardic responses. Similar to earlier reports (Glick and Braunwald, 1965; Coleman, 1980), the present

results obtained from sham-operated rats showed that the reflex bradycardic responses were mediated predominantly via increased cardiac vagal activity, because atropine caused approximately 60% reduction in BRS compared with only 20% in the case of propranolol. The effects of castration, cyclosporine, and their combination on the vagal contribution to reflex bradycardia paralleled their effects on BRS. The ability of atropine to reduce the predominantly vagally mediated reflex bradycardic responses was similarly attenuated in castrated rats and cyclosporine-treated rats. These findings suggest that testosterone depletion evoked surgically (by castration) or chemically (by cyclosporine) produced comparable impairment of the

352

El-Mas et al.

Fig. 5. Effect of ␤-adrenergic blockade by propranolol (1 mg/kg, i.v.) on baroreflex curves relating decreases in heart rate to phenylephrine-induced elevations in mean arterial pressure in conscious, freely moving, sham-operated, CAS and CAS ⫹ T rats in the presence and absence of CyA. Insets show the slopes (BRS, beats per minute per mm Hg) of the baroreflex curves. Values are expressed as mean ⫾ S.E.M.

vagal component. The view that the inhibitory effect of cyclosporine on vagal activity is testosterone-related gains further support from the observation that treatment of castrated rats with cyclosporine caused no additional decline in the overall contribution of the vagal component to reflex bradycardia. In effect, the reduction in BRS evoked by atropine in CAS ⫹ CyA rats was not statistically different from that of castrated rats. Collectively, these findings may plausibly suggest that cyclosporine counteracts testosterone-mediated baroreflex enhancement via compromising its facilitatory effect on the cardiac vagal control. It is important, however, before this conclusion is ac-

cepted, to comment on two potential limitations. The first relates to the possibility that the lack of an action of cyclosporine on BRS in castrated rats may be accounted for by the presence of a significantly lower baseline BRS in these rats as compared with sham-operated rats. It could be argued, therefore, that the BRS in castrated rats may have reached its nadir so that cyclosporine cannot depress it further. However, this issue may be addressed by the present finding that muscarinic blockade by atropine produced a significant attenuation of the BRS in castrated rats. The susceptibility of the remaining baroreceptor activity in castrated rats to additional attenuation by atropine rules out the possibility that its low levels can account


for the absence of cyclosporine effect on BRS in these rats. The second limitation pertains to the finding that cyclosporine significantly reduced BRS in testosterone-replaced castrated rats, which have restored physiological levels of the hormone. This finding should not be interpreted to argue against a modulatory role for testosterone in cyclosporine-baroreflex interaction. Instead, it may suggest that the inhibitory effects of cyclosporine on the baroreflex and vagal responses to testosterone are not due to inhibition of the testicular release of the hormone per se but due to the interaction of cyclosporine with specific receptors or sites within the baroreflex arc that mediate the hormone effect on baroreflex function. Possible targets for such interaction are the nucleus ambiguus and the dorsal motor nucleus of the vagus, brainstem areas in which androgen receptors have been identified (Sheridan and Weaker, 1982; Freeman, 1988) and are known to play a crucial role in the control of central vagal discharges (Ciriello and Calaresu, 1979; Van Giersbergen et al., 1992). More studies are needed, however, to determine the exact mechanism(s) involved in the interaction between cyclosporine and gonadal hormones on baroreflex function. The present finding that cyclosporine reduced the pressor responsiveness to phenylephrine deserves a comment. Whereas this finding is consistent with the reports that cyclosporine decreases ␣1-adrenoceptor responsiveness (Chiu et al., 1992), it raises the possibility that the altered vascular reactivity, rather than an impaired baroreflex function, might have contributed to the cyclosporine-induced decreases in the reflex bradycardic responses. Nonetheless, the reduction in the slope (BRS) of the baroreflex curve relating the pressor and reflex bradycardic responses to phenylephrine suggests an impairment of baroreceptor function by cyclosporine. This conclusion is further supported by the finding that attenuation of reflex bradycardic responses and BRS by cyclosporine were also demonstrated when doses of phenylephrine that caused similar pressor responses were considered (see Fig. 3). It is conceivable, therefore, to propose that the altered ␣1-adrenoceptor responsiveness has no impact on the cyclosporine-induced impairment of baroreflex function. In summary, the present study sought evidence to implicate androgens in the depressant effect of the immunosuppressant drug cyclosporine on baroreceptor control of HR in conscious rats. Short-term castration impaired, whereas testosterone replacement restored, BRS to sham-operated levels, suggesting a favorable effect for testosterone on baroreflexes. Cyclosporine decreased plasma testosterone levels and reduced BRS to levels similar to those of castrated rats. Muscarinic blockade by atropine remarkably reduced BRS, an effect that was comparably attenuated by castration, cyclosporine, or their combination. It is concluded that cyclosporine impairs baroreceptor control of reflex bradycardia via reducing plasma testosterone levels and interrupting the facilitatory effect of the hormone on the autonomic (vagal) control of the heart. The finding that CyA significantly reduced BRS in testosterone-replaced castrated rats, i.e., in the presence of physiological levels of the hormone, infers that CyA interferes with baroreflex and vagal functions through altering the interaction of testosterone at specific target sites controlling these functions.

353

Acknowledgments

We thank Novartis Pharma, AG (Basel, Switzerland) for generously supplying cyclosporine A. References Abdel-Rahman AA (1999) Gender difference in baroreflex-mediated bradycardia in young rats: role of cardiac sympathetic and parasympathetic components. Can J Physiol Pharmacol 77:358 –366. Abdel-Rahman AA and Wooles WR (1987) Ethanol-induced hypertension involves impairment of baroreceptors. Hypertension 10:67–73. Bowman AR, Sass DA, Dissanayaka IR, Ma YF, Liang H, Yuan Z, Jee WS, and Epstein S (1997) The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607– 615. Chen HI, Chapleau MW, McDowell TS, and Abboud FM (1990) Prostaglandins contribute to activation of baroreceptors in rabbits. Possible paracrine influence of endothelium. Circ Res 67:1394 –1404. Chiu PJS, Vemulapalli S, Sabin C, Rivelli M, Bernardino V, and Sybertz EJ (1992) Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats. J Pharmacol Exp Ther 261:994 –999. Ciriello J and Calaresu FR (1979) Separate medullary pathways mediating reflex vagal bradycardia to stimulation of buffer nerves in the cat. J Auton Nerv Syst 1:13–32. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, and Storm TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 101:667– 682. Coleman TG (1980) Arterial baroreflex control of heart rate in the conscious rat. Am J Physiol 238:H515–H520. El-Mas MM (1998) Facilitation of reflex bradycardia does not contribute to the enhanced hypotensive effect of clonidine in aortic barodenervated rats. J Cardiovasc Pharmacol 31:869 – 875. El-Mas MM (1999) Ethanol abolishes clonidine-induced impairment of baroreflex control of heart rate in conscious rats. Gen Pharmacol 32:207–214. El-Mas MM, Abdel-Galil AG, El-Gowelli HM, and Daabees TT (1997a) Short-term aortic barodenervation diminishes ␣1-adrenoceptor reactivity in rat aortic smooth muscle. Eur J Pharmacol 322:201–210. El-Mas MM and Abdel-Rahman AA (1992) Role of aortic baroreceptors in ethanolinduced impairment of baroreflex control of heart rate in conscious rats. J Pharmacol Exp Ther 262:157–165. El-Mas MM and Abdel-Rahman AA (1997) Aortic barodenervation upregulates ␣2adrenoceptors in the nucleus tractus solitarius and rostral ventrolateral medulla: an autoradiographic study. Neuroscience 79:581–590. El-Mas MM and Abdel-Rahman AA (1998) Ovariectomy abolishes ethanol-induced impairment of baroreflex control of heart rate in conscious rats. Eur J Pharmacol 349:253–261. El-Mas MM and Abdel-Rahman AA (1993) Role of NMDA and non-NMDA receptors in the nucleus tractus solitarius in the depressant effect of ethanol on baroreflexes. J Pharmacol Exp Ther 266:602– 610. El-Mas MM, Afify EA, Mohy El-Din MM, Omar AG, and Sharabi FM (2001) Testosterone facilitates the baroreceptor control of reflex bradycardia: role of cardiac sympathetic and parasympathetic components. J Cardiovasc Pharmacol 38:754 – 763. El-Mas MM, Daabees TT, El-Gowelli HM, and Abdel-Galil AA (1997b) Enhanced endothelial nitric oxide activity contributes to the reduced responsiveness of vascular ␣1-adrenoceptors following aortic barodenervation. Eur J Pharmacol 337: 235–243. Freeman ME (1988) The ovarian cycle of the rat, in The Physiology of Reproduction (Knobil E and Neil J eds) pp 1893–1928, Raven Press Ltd., New York. Gerhardt U, Riedasch M, and Hohage H (1999) Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 68:203–208. Glick G and Braunwald E (1965) Relative roles of the sympathetic and parasympathetic nervous system in the reflex control of heart rate. Circ Res 16:363–375. Goldstein DS (1983) Arterial baroreflex sensitivity, plasma catecholamines and pressor responsiveness in essential hypertension. Circulation 68:234 –240. Gordon FJ and Mark AL (1983) Impaired baroreflex control of vascular resistance in prehypertensive Dahl S rats. Am J Physiol 245:H210 –H217. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, and Hoover RL (1990) Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37:1487– 1491. Krueger BA, Trakshel GM, Sluss PM, and Maines MD (1991) Cyclosporine-mediated depression of luteinizing hormone receptors and hemebiosynthesis. Endocrinology 129:2647–2654. Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli F, and Pagani M (2000) Study of arterial and autonomic effects of cyclosporine in humans. Hypertension 35:1258 –1263. Mills TM, Wiedmeier VT, and Stopper VS (1992) Androgen maintenance of erectile function in the rat penis. Biol Reprod 46:342–348. Perico N, Benigni A, Zoja C, Delaini F, and Remuzzi G (1986) Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporine A. Am J Physiol 251:F581–F587. Ryuzaki M, Stahl LK, Lyson T, Victor RG, and Bishop VS (1997) Sympathoexcitatory response to cyclosporin A and baroreflex resetting. Hypertension 29:576 –582. Schachter M (1988) Cyclosporine A and hypertension. J Hypertens 6:511–516. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, and Victor RG (1990) Cyclosporine-induced sympathetic activation and hypertension after transplantation. N Engl J Med 323:693– 699. Schwartz PJ, Billman GE, and Stone HL (1984) Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with a healed infarction: an experimental preparation for sudden cardiac death. Circulation 69:780 –790.

354

El-Mas et al.

Seethalakshmi L, Flores C, Carboni AA, and Menon M (1990) Quantitative maintenance of spermatogenesis in cyclosporine-treated rats by exogenous administration of testosterone propionate. J Androl 11:491– 497. Seidenfeld J, Wilson J, and Williams-Ashman HG (1980) Androgenic regulation of 5⬘-deoxy-5⬘-methylthioadenosine concentrations and methylthioadenosine phosphorylase activity in relation to polyamine metabolism of rat prostate. Biochem Biophys Res Commun 95:1861–1868. Sheridan PJ and Weaker FJ (1982) Androgen receptor systems in the brain stem of the primate. Brain Res 235:225–232. Srinivas M, Agarwala S, Datta Gupta S, Das SN, Jha P, Misro MM, and Mitra DK (1998) Effect of cyclosporine on fertility in male rats. Pediatr Surg Int 13:388 –391. Tsuji H, Venditti F Jr, Manders ES, Evans JC, Larson MG, Feldman CL, and Levy

D (1994) Reduced heart rate variability and mortality risk in an elderly cohort. Circulation 90:878 – 883. Van Giersbergen PLM, Palkovits M, and De Jong W (1992) Involvement of neurotransmitters in the nucleus tractus solitarii in cardiovascular regulation. Physiol Rev 72:789 – 824. Xue H, Bukoski RD, McCarron DA, and Bennett MW (1987) Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 43:715–718.

Address correspondence to: Dr. Mahmoud M. El-Mas, Department of Pharmacology, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt. E-mail: [email protected]